Zemdri (plazomicin) Injection
Product Images NDC 71045-010

2 FDA label images from Achaogen, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Zemdri (plazomicin) (NDC 71045-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Achaogen, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zemdri 01)

Chemical Structure (Zemdri 01)
Chemical structure of plazomicin, the active ingredient in Zemdri injection 500 mg/10 mL by Achaogen, Inc. The diagram shows the molecular arrangement including rings, amine, hydroxyl groups, and sulfate salt (2.5H2SO4) notation.*
FDA Label Image

Principal Display Panel (10 mL Vial Carton)

Principal Display Panel (10 mL Vial Carton)
The packaging label for Zemdri (plazomicin) Injection 500 mg/10 mL single-dose vials. The label indicates intravenous infusion use only and the need to dilute before use. The carton contains 10 vials, each with 500 mg plazomicin in 10 mL. The labeler is Achaogen, Inc., with storage instructions to refrigerate at 2°C to 8°C. The label includes NDC 71045-010-02 and the barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.